{"id":8492,"date":"2026-09-17T13:40:55","date_gmt":"2026-09-17T17:40:55","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/notre-histoire\/"},"modified":"2026-11-11T05:25:45","modified_gmt":"2026-11-11T04:25:45","slug":"notre-histoire","status":"publish","type":"page","link":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/","title":{"rendered":"Notre histoire"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqvfvik7-92944530a504a0d85596563df5fae15b\">\n.avia-section.av-mqvfvik7-92944530a504a0d85596563df5fae15b{\nbackground-color:#0e1539;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-mqvfvik7-92944530a504a0d85596563df5fae15b main_color avia-section-huge avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  invalid-custom-class-found page-banner unset-row avia-bg-style-scroll container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8492'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqvgbvo2-99044bede1a8a1b07292fdb204e1f3e6\">\n.avia-image-container.av-mqvgbvo2-99044bede1a8a1b07292fdb204e1f3e6 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-mqvgbvo2-99044bede1a8a1b07292fdb204e1f3e6 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-mqvgbvo2-99044bede1a8a1b07292fdb204e1f3e6 av-styling- av-hover-fade avia-align-center  avia-builder-el-1  el_before_av_two_third  avia-builder-el-first  center-right-dots animated-dots flip-dots buffer-right'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" fetchpriority=\"high\" class='wp-image-8016 avia-img-lazy-loading-not-8016 avia_image fade-basic' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-1.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><img decoding=\"async\" class='wp-image-8019 avia-img-lazy-loading-not-8019 avia_image fade-overlay' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-2.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div>\n<div  class='flex_column av-gqe85-fccb89636dbb2dfeb2d251de1370f59a av_two_third  avia-builder-el-2  el_after_av_image  avia-builder-el-last  first flex_column_div av-animated-generic fade-in  '     ><section  class='av_textblock_section av-avwal-9aae7976204d416cba9af293fed5851f '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock page-banner-content'  itemprop=\"text\" ><h1>Notre histoire<\/h1>\n<p>En 2012, un groupe de scientifiques fonde GenSight Biologics avec l&rsquo;ambition d&rsquo;appliquer les avanc\u00e9es de la th\u00e9rapie g\u00e9nique pour d\u00e9velopper des traitements susceptibles de transformer la vie des patients atteints de maladies h\u00e9r\u00e9ditaires c\u00e9citantes.<\/p>\n<p>Depuis, GenSight Biologics franchit des \u00e9tapes majeures. Nos candidats-m\u00e9dicaments sont pass\u00e9s du concept scientifique au d\u00e9veloppement clinique, avec une preuve de concept chez l&rsquo;humain, nous rapprochant de notre ambition.<\/p>\n<\/div><\/section><\/div>\n\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqvgmd9k-c997e6f0474ba972c6340b38b6405572\">\n.avia-section.av-mqvgmd9k-c997e6f0474ba972c6340b38b6405572{\nbackground-color:#0e1539;\nbackground-image:url(https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/radial-1.png);\nbackground-repeat:no-repeat;\nbackground-position:100% 50%;\nbackground-attachment:scroll;\n}\n<\/style>\n<div id='av_section_2'  class='avia-section av-mqvgmd9k-c997e6f0474ba972c6340b38b6405572 main_color avia-section-large avia-no-border-styling  avia-builder-el-4  el_after_av_section  el_before_av_section  light-blue-container-row avia-full-contain avia-bg-style-scroll container_wrap sidebar_right'  data-section-bg-repeat='contain'><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8492'><div class='entry-content-wrapper clearfix'>\n<div class='flex_column_table av-gd98d-e27d61ae0c75a67b158d5953346d498e sc-av_one_half av-break-at-tablet-flextable av-equal-height-column-flextable'><div  class='flex_column av-gd98d-e27d61ae0c75a67b158d5953346d498e av_one_half  avia-builder-el-5  el_before_av_one_half  avia-builder-el-first  image-column first no_margin av-break-at-tablet flex_column_table_cell av-equal-height-column av-align-middle  '     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqvhw4t6-ddd16172dd31c4ca579f08fc6e690b10\">\n.avia-image-container.av-mqvhw4t6-ddd16172dd31c4ca579f08fc6e690b10 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-mqvhw4t6-ddd16172dd31c4ca579f08fc6e690b10 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-mqvhw4t6-ddd16172dd31c4ca579f08fc6e690b10 av-styling- avia_animated_image av-animated-when-visible-95 fade-in avia-align-left  avia-builder-el-6  avia-builder-el-no-sibling '   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" class='wp-image-7806 avia-img-lazy-loading-not-7806 avia_image ' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/Our-Goal-Cropped-2.png\" alt='' title='Our-Goal-Cropped-2'  height=\"736\" width=\"886\"  itemprop=\"thumbnailUrl\" srcset=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/Our-Goal-Cropped-2.png 886w, https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/Our-Goal-Cropped-2-300x249.png 300w, https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/Our-Goal-Cropped-2-768x638.png 768w, https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/Our-Goal-Cropped-2-705x586.png 705w\" sizes=\"(max-width: 886px) 100vw, 886px\" \/><\/div><\/div><\/div><\/div><div  class='flex_column av-mqvhxbmk-d72b5ee4cf2e17ba338dc3d6cbc04c1f av_one_half  avia-builder-el-7  el_after_av_one_half  avia-builder-el-last  padding-col no_margin av-break-at-tablet flex_column_table_cell av-equal-height-column av-align-middle av-animated-generic right-to-left  '     ><section  class='av_textblock_section av-mqvi2jm9-775960a0b73387d718996cdc88b22675 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock blue-text'  itemprop=\"text\" ><h2>Notre objectif<\/h2>\n<p>L&rsquo;\u0153il est l&rsquo;une des cibles les plus prometteuses pour la th\u00e9rapie g\u00e9nique, et le si\u00e8ge de maladies h\u00e9r\u00e9ditaires rares pour lesquelles les solutions th\u00e9rapeutiques restent limit\u00e9es. Aujourd&rsquo;hui, nous d\u00e9veloppons des candidats-m\u00e9dicaments dans les maladies ophtalmiques neurod\u00e9g\u00e9n\u00e9ratives telles que la Neuropathie Optique H\u00e9r\u00e9ditaire de Leber (NOHL) et la R\u00e9tinite Pigmentaire (RP).<\/p>\n<p>Au-del\u00e0 de l&rsquo;ophtalmologie, nos plateformes technologiques ont la capacit\u00e9 de r\u00e9pondre \u00e0 d&rsquo;autres troubles du syst\u00e8me nerveux central.<\/p>\n<\/div><\/section><\/div><\/div><!--close column table wrapper. Autoclose: 1 -->\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqvi3c4r-ce1af271af88ae6779df2ea5b77ad5a9\">\n.avia-section.av-mqvi3c4r-ce1af271af88ae6779df2ea5b77ad5a9{\nbackground-color:#0e1539;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_3'  class='avia-section av-mqvi3c4r-ce1af271af88ae6779df2ea5b77ad5a9 main_color avia-section-huge avia-no-border-styling  avia-builder-el-9  el_after_av_section  el_before_av_section  background-radial-top-offset medium-padding-bottom bring-row-forward avia-bg-style-parallax container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8492'><div class='entry-content-wrapper clearfix'>\n<div  class='flex_column av-adi99-319b9c4c877f60124a516412b76b4434 av_one_full  avia-builder-el-10  avia-builder-el-no-sibling  first flex_column_div av-animated-generic bottom-to-top  '     ><section  class='av_textblock_section av-mqvi4auv-f31baa1926b207b1007142d25b537871 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock journey-textblock'  itemprop=\"text\" ><h2>Le parcours de GenSight Biologics<\/h2>\n<p>L&rsquo;histoire de GenSight Biologics est marqu\u00e9e par des avanc\u00e9es scientifiques, cliniques et financi\u00e8res qui nous rapprochent progressivement de traitements pour des patients confront\u00e9s \u00e0 des besoins m\u00e9dicaux majeurs non satisfaits.<\/p>\n<\/div><\/section><br \/>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzco004-b17dad776fcd0a038f431f93784bedcd\">\n#top .hr.hr-invisible.av-mqzco004-b17dad776fcd0a038f431f93784bedcd{\nheight:50px;\n}\n<\/style>\n<div  class='hr av-mqzco004-b17dad776fcd0a038f431f93784bedcd hr-invisible  avia-builder-el-12  el_after_av_textblock  el_before_av_textblock '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div><br \/>\n<section  class='av_textblock_section av-mqvigidi-8d69ef732cbd19052023c259484b835b '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock featured-journey'  itemprop=\"text\" ><!-- Gridbuilder \u1d42\u1d3e Plugin (https:\/\/wpgridbuilder.com) -->\n<div class=\"wp-grid-builder wpgb-grid-2\" data-options=\"{&quot;id&quot;:2,&quot;type&quot;:&quot;masonry&quot;,&quot;source&quot;:&quot;post_type&quot;,&quot;loader&quot;:false,&quot;layout&quot;:&quot;horizontal&quot;,&quot;reveal&quot;:0,&quot;isMainQuery&quot;:0,&quot;lazyLoad&quot;:false,&quot;cardSizes&quot;:{&quot;9999&quot;:{&quot;columns&quot;:3,&quot;height&quot;:240,&quot;gutter&quot;:20,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;1280&quot;:{&quot;columns&quot;:3,&quot;height&quot;:220,&quot;gutter&quot;:20,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;1024&quot;:{&quot;columns&quot;:2,&quot;height&quot;:200,&quot;gutter&quot;:20,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;640&quot;:{&quot;columns&quot;:1,&quot;height&quot;:200,&quot;gutter&quot;:20,&quot;ratio&quot;:&quot;1.33333&quot;}},&quot;fitRows&quot;:false,&quot;equalRows&quot;:0,&quot;equalColumns&quot;:true,&quot;fillLastRow&quot;:0,&quot;centerLastRow&quot;:0,&quot;horizontalOrder&quot;:false,&quot;fullWidth&quot;:false,&quot;transitionDelay&quot;:100,&quot;gallerySlideshow&quot;:false,&quot;rowsNumber&quot;:1,&quot;slideAlign&quot;:&quot;left&quot;,&quot;groupCells&quot;:1,&quot;draggable&quot;:true,&quot;initialIndex&quot;:0,&quot;contain&quot;:false,&quot;freeScroll&quot;:false,&quot;freeFriction&quot;:&quot;0.075&quot;,&quot;friction&quot;:&quot;0.285&quot;,&quot;attraction&quot;:&quot;0.025&quot;,&quot;autoPlay&quot;:0,&quot;pageDotAriaLabel&quot;:&quot;Point de page %d&quot;,&quot;isPreview&quot;:false,&quot;isGutenberg&quot;:false,&quot;rightToLeft&quot;:false}\"><div class=\"wpgb-svg-icons\" hidden>\n\t<svg viewBox=\"0 0 120 24\" width=\"0\" height=\"0\">\n\t<defs>\n        <polygon id=\"wpgb-star-svg\" points=\"12 2.5 15.1 8.8 22 9.8 17 14.6 18.2 21.5 12 18.3 5.8 21.5 7 14.6 2 9.8 8.9 8.8\"><\/polygon>\n    <\/defs>\n    <symbol id=\"wpgb-rating-stars-svg\">\n        <use xlink:href=\"#wpgb-star-svg\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"24\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"48\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"72\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"96\"><\/use>\n    <\/symbol>\n<\/svg>\n<\/div>\n<div class=\"wpgb-wrapper\">\n\t<div class=\"wpgb-main\">\n\t<div class=\"wpgb-layout\">\n\t<div class=\"wpgb-viewport\">\n\t\t<div class=\"wpgb-masonry\">\n\t\t\t<article class=\"wpgb-card wpgb-card-2 wpgb-post-8507\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Avril 2012<\/div><\/div><h3 class=\"wpgb-block-2\">Fondation de GenSight Biologics<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">GenSight Biologics est fond\u00e9e \u00e0 Paris par un groupe de scientifiques, anim\u00e9s \u00e0 la fois par la curiosit\u00e9 scientifique et par la volont\u00e9 de concr\u00e9tiser le potentiel th\u00e9rapeutique de la th\u00e9rapie g\u00e9nique dans les maladies c\u00e9citantes.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8509\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">F\u00e9vrier 2014<\/div><\/div><h3 class=\"wpgb-block-2\">Premier essai clinique chez l&rsquo;homme avec GS010<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">Le premier des 15 patients est inclus dans REVEAL, la premi\u00e8re \u00e9tude clinique chez l&rsquo;homme dans la NOHL li\u00e9e \u00e0 la mutation <em>ND4<\/em>. Cette \u00e9tude de phase 1\/2 est con\u00e7ue pour \u00e9valuer la s\u00e9curit\u00e9 et l&rsquo;efficacit\u00e9 d&rsquo;une injection unique de th\u00e9rapie g\u00e9nique.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8510\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">F\u00e9vrier 2016<\/div><\/div><h3 class=\"wpgb-block-2\">Premi\u00e8res \u00e9tudes de Phase 3 pour GS010<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">Les premiers patients sont recrut\u00e9s dans RESCUE (39 patients) et REVERSE (37 patients), deux \u00e9tudes de Phase 3 conduites en parall\u00e8le afin d&rsquo;\u00e9valuer l&rsquo;efficacit\u00e9 d&rsquo;une injection unilat\u00e9rale unique.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8511\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Juillet 2016<\/div><\/div><h3 class=\"wpgb-block-2\">Introduction en Bourse<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">GenSight Biologics s&rsquo;introduit sur Euronext Paris et l\u00e8ve environ 40 millions d&rsquo;euros pour soutenir les phases avanc\u00e9es du d\u00e9veloppement de GS010.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8512\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Mars 2018<\/div><\/div><h3 class=\"wpgb-block-2\">Troisi\u00e8me \u00e9tude de Phase 3 pour GS010<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">Le premier des 98 patients est recrut\u00e9 dans REFLECT, troisi\u00e8me \u00e9tude de Phase 3, con\u00e7ue pour \u00e9valuer la s\u00e9curit\u00e9 et l&rsquo;efficacit\u00e9 d&rsquo;injections bilat\u00e9rales. Avec RESCUE et REVERSE, le programme clinique de Phase 3 comprend un total de 174 patients trait\u00e9s.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8513\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Octobre 2018<\/div><\/div><h3 class=\"wpgb-block-2\">Premier essai chez l&rsquo;homme avec GS030<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">Le premier patient est recrut\u00e9 dans PIONEER, premi\u00e8re \u00e9tude de Phase 1\/2 chez l&rsquo;homme \u00e9valuant GS030, un traitement optog\u00e9n\u00e9tique innovant qui associe une th\u00e9rapie g\u00e9nique \u00e0 un dispositif de stimulation lumineuse port\u00e9 par le patient. Ce programme s&rsquo;adresse aux personnes aveugles atteintes de R\u00e9tinite Pigmentaire (RP) avanc\u00e9e.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8514\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">D\u00e9cembre 2019<\/div><\/div><h3 class=\"wpgb-block-2\">Premier patient en acc\u00e8s pr\u00e9coce<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">L&rsquo;ANSM accorde la premi\u00e8re Autorisation Temporaire d&rsquo;Utilisation (ATU) nominative pour GS010, permettant de traiter un patient en dehors d&rsquo;un essai clinique. L&rsquo;acc\u00e8s pr\u00e9coce s&rsquo;\u00e9tend ensuite \u00e0 des patients en Italie, au Royaume-Uni et aux \u00c9tats-Unis.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8515\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Avril 2023<\/div><\/div><h3 class=\"wpgb-block-2\">Retrait de la demande d&rsquo;AMM aupr\u00e8s de l&rsquo;EMA pour GS010\/LUMEVOQ\u00ae<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">GenSight Biologics retire volontairement sa demande d&rsquo;autorisation europ\u00e9enne de mise sur le march\u00e9 pour GS010\/LUMEVOQ\u00ae, \u00e0 la suite d&rsquo;un effet controlat\u00e9ral inattendu observ\u00e9 lors des essais de Phase 3, qui a compliqu\u00e9 la d\u00e9monstration de l&rsquo;efficacit\u00e9. Apr\u00e8s de nouveaux \u00e9changes avec l&rsquo;EMA et la FDA, la Soci\u00e9t\u00e9 accepte de conduire un nouvel essai de Phase 3, RECOVER, fond\u00e9 sur les enseignements des essais pr\u00e9c\u00e9dents. <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8516\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">D\u00e9cembre 2023<\/div><\/div><h3 class=\"wpgb-block-2\">Une nouvelle direction<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">Laurence Rodriguez est nomm\u00e9e directrice g\u00e9n\u00e9rale. Forte de plus de 30 ans d&rsquo;exp\u00e9rience dans les sciences de la vie et les maladies rares, elle a pour mission de diriger la Soci\u00e9t\u00e9 \u00e0 l&rsquo;aube d&rsquo;une nouvelle phase de son d\u00e9veloppement. Jan Eryk Umiastowski rejoint GenSight Biologics comme directeur financier en 2024.  <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8517\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">D\u00e9cembre 2025<\/div><\/div><h3 class=\"wpgb-block-2\">\u00c9tude REVISE et programmes d&rsquo;acc\u00e8s pr\u00e9coce<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">L\u2019ANSM autorise REVISE, une \u00e9tude de Phase 2 \u00e9valuant diff\u00e9rentes doses de GS010 en France. Parall\u00e8lement, une autorisation d\u2019acc\u00e8s compassionnel (AAC) \u00e0 GS010 est accord\u00e9e en France. Cette d\u00e9cision intervient apr\u00e8s des autorisations d\u2019acc\u00e8s d\u00e9rogatoire \u00e0 GS010 accord\u00e9es aux \u00c9tats-Unis et en Isra\u00ebl. <\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-2 wpgb-post-8518\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><div class=\"wpgb-block-3\">Perspectives<\/div><\/div><h3 class=\"wpgb-block-2\">\u00c9crire le prochain chapitre<\/h3><div class=\"wpgb-block-5\">\n<p class=\"wp-block-paragraph\">GenSight Biologics pr\u00e9pare le lancement de RECOVER, l&rsquo;\u00e9tude pivotale internationale de Phase 3 de GS010, tout en continuant d&rsquo;explorer des possibilit\u00e9s d&rsquo;acc\u00e8s d\u00e9rogatoire dans plusieurs pays afin de r\u00e9pondre \u00e0 des besoins th\u00e9rapeutiques non satisfaits.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/article>\t\t<\/div>\n\t<\/div>\n\t<div class=\"wpgb-area wpgb-area-left\">\n\t<button type=\"button\" class=\"wpgb-prev-button\" aria-label=\"Diapositive pr\u00e9c\u00e9dente\" hidden>\n\t<svg><use xlink:href=\"https:\/\/www.gensight-biologics.com\/wp-content\/plugins\/wp-grid-builder\/public\/svg\/arrows\/arrow-left.svg#wpgb-icon\"\/><\/svg><\/button>\n<\/div>\n<div class=\"wpgb-area wpgb-area-right\">\n\t<button type=\"button\" class=\"wpgb-next-button\" aria-label=\"Diapositive suivante\" hidden>\n\t<svg><use xlink:href=\"https:\/\/www.gensight-biologics.com\/wp-content\/plugins\/wp-grid-builder\/public\/svg\/arrows\/arrow-right.svg#wpgb-icon\"\/><\/svg><\/button>\n<\/div>\n<\/div>\n<div class=\"wpgb-area wpgb-area-bottom-1\">\n\t<button type=\"button\" class=\"wpgb-prev-button\" aria-label=\"Diapositive pr\u00e9c\u00e9dente\" hidden>\n\t<svg><use xlink:href=\"https:\/\/www.gensight-biologics.com\/wp-content\/plugins\/wp-grid-builder\/public\/svg\/arrows\/arrow-left.svg#wpgb-icon\"\/><\/svg><\/button>\n<button type=\"button\" class=\"wpgb-next-button\" aria-label=\"Diapositive suivante\" hidden>\n\t<svg><use xlink:href=\"https:\/\/www.gensight-biologics.com\/wp-content\/plugins\/wp-grid-builder\/public\/svg\/arrows\/arrow-right.svg#wpgb-icon\"\/><\/svg><\/button>\n<\/div>\n\t<\/div>\n\t\t<\/div>\n<\/div>\n\n<\/div><\/section><\/p><\/div>\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqze5ot2-0ba859d50f9441a4a9e1446b50a4109e\">\n.avia-section.av-mqze5ot2-0ba859d50f9441a4a9e1446b50a4109e{\nbackground-color:#0e1539;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_4'  class='avia-section av-mqze5ot2-0ba859d50f9441a4a9e1446b50a4109e main_color avia-section-large avia-no-border-styling  unset-row flex-row no-padding-top avia-bg-style-scroll container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8492'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzdkh37-9aea6c4eb3d681ed7aa7dd3862255727\">\n.avia-image-container.av-mqzdkh37-9aea6c4eb3d681ed7aa7dd3862255727 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-mqzdkh37-9aea6c4eb3d681ed7aa7dd3862255727 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-mqzdkh37-9aea6c4eb3d681ed7aa7dd3862255727 av-styling- av-hover-fade avia-align-center  offset-top top-left-dots-img animated-dots'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" class='wp-image-8016 avia-img-lazy-loading-not-8016 avia_image fade-basic' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-1.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><img decoding=\"async\" class='wp-image-8019 avia-img-lazy-loading-not-8019 avia_image fade-overlay' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-2.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div>\n<div  class='flex_column av-9u3yd-799ad7b8e1528403b6c817a975a3baf6 av_one_full first flex_column_div av-animated-generic fade-in  '     ><section  class='av_textblock_section av-mqzdhg6h-259f8e76dd0e1f1f59a11e6e3d7a9b6b '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><h2 style=\"text-align: center\">Qui sommes-nous ?<\/h2>\n<p style=\"text-align: center\">D\u00e9couvrez l&rsquo;\u00e9quipe qui \u00e9crit le prochain chapitre de GenSight Biologics.<\/p>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzfz95a-91d28093225a3a459c05acf121f2b838\">\n.flex_column.av-mqzfz95a-91d28093225a3a459c05acf121f2b838{\nwidth:31%;\n}\n<\/style>\n<div  class='flex_column av-mqzfz95a-91d28093225a3a459c05acf121f2b838 av_one_third  light-blue-box first flex_column_div av-animated-generic bottom-to-top avia-link-column av-column-link  '    data-link-column-url=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/direction\/\"   ><a class=\"av-screen-reader-only\" href=https:\/\/www.gensight-biologics.com\/fr\/societe\/direction\/ >Lier vers : Direction<\/a><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzhhzrp-44a92850a2f8588638e92842d7722ce4\">\n.avia-image-container.av-mqzhhzrp-44a92850a2f8588638e92842d7722ce4 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-mqzhhzrp-44a92850a2f8588638e92842d7722ce4 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-mqzhhzrp-44a92850a2f8588638e92842d7722ce4 av-styling- avia-align-center'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" class='wp-image-8498 avia-img-lazy-loading-not-8498 avia_image ' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-2.png\" alt='' title='Rectangle 845 (2)'  height=\"259\" width=\"413\"  itemprop=\"thumbnailUrl\" srcset=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-2.png 413w, https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-2-300x188.png 300w\" sizes=\"(max-width: 413px) 100vw, 413px\" \/><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-mqzfqy43-a239faf4310f5880ff1372b5b7888b0b '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><h3 style=\"text-align: left\">Direction<\/h3>\n<p style=\"text-align: left\">Notre \u00e9quipe de direction d\u00e9finit la strat\u00e9gie, supervise les op\u00e9rations et porte la vision scientifique de GenSight Biologics. Ensemble, nous faisons progresser des approches de th\u00e9rapie g\u00e9nique au service des patients atteints de maladies h\u00e9r\u00e9ditaires rares et graves. <\/p>\n<p><a class=\"a-link-with-arrow\" href=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/direction\/\">En savoir plus<\/a><\/p>\n<\/div><\/section><\/p><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzglg86-8ec651033532e955e36f1da7f42cd99b\">\n.flex_column.av-mqzglg86-8ec651033532e955e36f1da7f42cd99b{\nwidth:31%;\nmargin-left:3.5%;\n}\n<\/style>\n<div  class='flex_column av-mqzglg86-8ec651033532e955e36f1da7f42cd99b av_one_third  light-blue-box flex_column_div av-animated-generic bottom-to-top avia-link-column av-column-link  '    data-link-column-url=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/conseil-dadministration\/\"   ><a class=\"av-screen-reader-only\" href=https:\/\/www.gensight-biologics.com\/fr\/societe\/conseil-dadministration\/ >Lier vers : Conseil d&rsquo;administration<\/a><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mqzhit6o-bcf7a58642e9bc972e54ba8cf7e1ac8b\">\n.avia-image-container.av-mqzhit6o-bcf7a58642e9bc972e54ba8cf7e1ac8b img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-mqzhit6o-bcf7a58642e9bc972e54ba8cf7e1ac8b .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-mqzhit6o-bcf7a58642e9bc972e54ba8cf7e1ac8b av-styling- avia-align-center'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" class='wp-image-8499 avia-img-lazy-loading-not-8499 avia_image ' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-1.png\" alt='' title='Rectangle 845 (1)'  height=\"259\" width=\"413\"  itemprop=\"thumbnailUrl\" srcset=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-1.png 413w, https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/06\/Rectangle-845-1-300x188.png 300w\" sizes=\"(max-width: 413px) 100vw, 413px\" \/><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-mqzga0ps-6fd8f3b28295e983b0354ca0b619249e '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><h3 style=\"text-align: left\">Conseil d&rsquo;administration<\/h3>\n<p style=\"text-align: left\">Notre Conseil d&rsquo;administration r\u00e9unit une solide expertise en biotechnologies et en gouvernance d&rsquo;entreprise pour accompagner la vision strat\u00e9gique et le d\u00e9veloppement de GenSight Biologics.<\/p>\n<p><a class=\"a-link-with-arrow\" href=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/conseil-dadministration\/\">En savoir plus<\/a><\/p>\n<\/div><\/section><\/p><\/div><\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='after_section_4'  class='main_color av_default_container_wrap container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8492'><div class='entry-content-wrapper clearfix'>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":8767,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8492","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Notre histoire | GenSight Biologics<\/title>\n<meta name=\"description\" content=\"D\u00e9couvrez les ambitions et l&#039;histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre histoire | GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"D\u00e9couvrez les ambitions et l&#039;histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-11T04:25:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/11\/Gensight-Logo-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/notre-histoire\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/notre-histoire\\\/\",\"name\":\"Notre histoire | GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-09-17T17:40:55+00:00\",\"dateModified\":\"2026-11-11T04:25:45+00:00\",\"description\":\"D\u00e9couvrez les ambitions et l'histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/notre-histoire\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/notre-histoire\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/notre-histoire\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soci\u00e9t\u00e9\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/societe\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Notre histoire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#organization\",\"name\":\"GenSight Biologics\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Gensight-Logo-2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.gensight-biologics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Gensight-Logo-2.jpg\",\"width\":696,\"height\":696,\"caption\":\"GenSight Biologics\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/8104807?trk=prof-exp-company-name\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre histoire | GenSight Biologics","description":"D\u00e9couvrez les ambitions et l'histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/","og_locale":"fr_FR","og_type":"article","og_title":"Notre histoire | GenSight Biologics","og_description":"D\u00e9couvrez les ambitions et l'histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.","og_url":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/","og_site_name":"GenSight Biologics","article_modified_time":"2026-11-11T04:25:45+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/11\/Gensight-Logo-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/","url":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/","name":"Notre histoire | GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2026-09-17T17:40:55+00:00","dateModified":"2026-11-11T04:25:45+00:00","description":"D\u00e9couvrez les ambitions et l'histoire de GenSight Biologics, de sa cr\u00e9ation \u00e0 ses programmes actuels de th\u00e9rapie g\u00e9nique d\u00e9di\u00e9s \u00e0 la vision.","breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/societe\/notre-histoire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Soci\u00e9t\u00e9","item":"https:\/\/www.gensight-biologics.com\/fr\/societe\/"},{"@type":"ListItem","position":3,"name":"Notre histoire"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","publisher":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.gensight-biologics.com\/fr\/#organization","name":"GenSight Biologics","url":"https:\/\/www.gensight-biologics.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/11\/Gensight-Logo-2.jpg","contentUrl":"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/11\/Gensight-Logo-2.jpg","width":696,"height":696,"caption":"GenSight Biologics"},"image":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/8104807?trk=prof-exp-company-name"]}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=8492"}],"version-history":[{"count":12,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8492\/revisions"}],"predecessor-version":[{"id":10569,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8492\/revisions\/10569"}],"up":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8767"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=8492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}